Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H B Wu

Showing results (1-10 of 334) with videos related to

Pageof 34
Sort By:
Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum|August 23, 2005
Markers for early detection of cardiac diseasesAlan H B Wu
Laboratory Medicine|December 14, 2024
The importance of hemolysis detection among neonates for interpretation of potassium resultsAlan H B Wu
Clinical Pharmacology and Therapeutics|August 21, 2010
Limitations of point-of-care testing in the ED or ICU: a role for regional centralized toxicology laboratoriesA H B Wu
Biomarkers in Medicine|May 19, 2010
Early detection of acute coronary syndromes and risk stratification by multimarker analysisAlan H B Wu
The Journal of Applied Laboratory Medicine|October 23, 2019
"On Vivo" and Wearable Clinical Laboratory Testing Devices for Emergency and Critical Care Laboratory TestingAlan H B Wu
MLO: Medical Laboratory Observer|July 5, 2003
The ischemia-modified albumin biomarker for myocardial ischemiaAlan H B Wu
Pharmacogenomics|February 5, 2008
Use of genetic and nongenetic factors in warfarin dosing algorithmsAlan H B Wu
American Heart Journal|October 31, 2006
Serial testing of B-type natriuretic peptide and NTpro-BNP for monitoring therapy of heart failure: the role of biologic variation in the interpretation of resultsAlan H B Wu
Clinics in Laboratory Medicine|February 11, 2014
Biomarkers for cholesterol absorption and synthesis in hyperlipidemic patients: role for therapeutic selectionAlan H B Wu
EJIFCC|September 30, 2016
Biomarkers Beyond the Natriuretic Peptides for Chronic Heart Failure: Galectin-3 and Soluble ST2Alan H B Wu
Pageof 34

Showing results (1-10 of 334) with videos related to

Sort By:
Pageof 34
Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum|August 23, 2005
Markers for early detection of cardiac diseasesAlan H B Wu
Laboratory Medicine|December 14, 2024
The importance of hemolysis detection among neonates for interpretation of potassium resultsAlan H B Wu
Clinical Pharmacology and Therapeutics|August 21, 2010
Limitations of point-of-care testing in the ED or ICU: a role for regional centralized toxicology laboratoriesA H B Wu
Biomarkers in Medicine|May 19, 2010
Early detection of acute coronary syndromes and risk stratification by multimarker analysisAlan H B Wu
The Journal of Applied Laboratory Medicine|October 23, 2019
"On Vivo" and Wearable Clinical Laboratory Testing Devices for Emergency and Critical Care Laboratory TestingAlan H B Wu
MLO: Medical Laboratory Observer|July 5, 2003
The ischemia-modified albumin biomarker for myocardial ischemiaAlan H B Wu
Pharmacogenomics|February 5, 2008
Use of genetic and nongenetic factors in warfarin dosing algorithmsAlan H B Wu
American Heart Journal|October 31, 2006
Serial testing of B-type natriuretic peptide and NTpro-BNP for monitoring therapy of heart failure: the role of biologic variation in the interpretation of resultsAlan H B Wu
Clinics in Laboratory Medicine|February 11, 2014
Biomarkers for cholesterol absorption and synthesis in hyperlipidemic patients: role for therapeutic selectionAlan H B Wu
EJIFCC|September 30, 2016
Biomarkers Beyond the Natriuretic Peptides for Chronic Heart Failure: Galectin-3 and Soluble ST2Alan H B Wu
Pageof 34